Loading data for NAMSW — first visit, this takes a few seconds.
NewAmsterdam Pharma N.V. (NAMSW)
NasdaqGM: NAMSW
· 실시간 가격 · USD
16.00
+0.00 (0.00%)
종가 기준: Aug 18, 2026, 6:21 PM
NewAmsterdam Pharma N.V. (NAMSW) Stock Price, Analysis & Data
0.00% (1D)
데이터 없음
NAMSW 소개
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is ...
전체 기업 정보재무 실적
2025년 NewAmsterdam Pharma의 매출은 22.5M로, 전년 45.56M 대비 -50.61% 감소했습니다. 순이익은 -203.82M로, -15.64% 감소했습니다.
재무제표